146 related articles for article (PubMed ID: 19563615)
21. Roles for p21waf1/cip1 and p27kip1 during the adaptation response to massive intestinal resection.
Stehr W; Bernal NP; Erwin CR; Bernabe KQ; Guo J; Warner BW
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G933-41. PubMed ID: 16322092
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
Wong SC; Chan JK; Lee KC; Hsiao WL
J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
[TBL] [Abstract][Full Text] [Related]
24. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting.
Leville CD; Osipov VO; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
Surgery; 2000 Aug; 128(2):178-84. PubMed ID: 10922989
[TBL] [Abstract][Full Text] [Related]
25. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
26. Early adaptive responses of the vascular wall during venous arterialization in mice.
Kwei S; Stavrakis G; Takahas M; Taylor G; Folkman MJ; Gimbrone MA; García-Cardeña G
Am J Pathol; 2004 Jan; 164(1):81-9. PubMed ID: 14695322
[TBL] [Abstract][Full Text] [Related]
27. Cyclic stretch-induced Crp3 sensitizes vascular smooth muscle cells to apoptosis during vein arterialization remodeling.
Campos LCG; Ribeiro-Silva JC; Menegon AS; Barauna VG; Miyakawa AA; Krieger JE
Clin Sci (Lond); 2018 Feb; ():. PubMed ID: 29437853
[TBL] [Abstract][Full Text] [Related]
28. Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.
Wang GJ; Sui XX; Simosa HF; Jain MK; Altieri DC; Conte MS
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2081-7. PubMed ID: 16123317
[TBL] [Abstract][Full Text] [Related]
29. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-365 promotes the contractile phenotype of venous smooth muscle cells and inhibits neointimal formation in rat vein grafts.
Cao BJ; Zhu L; Wang XW; Zou RJ; Lu ZQ
IUBMB Life; 2019 Jul; 71(7):908-916. PubMed ID: 30746857
[TBL] [Abstract][Full Text] [Related]
31. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
Kavurma MM; Khachigian LM
J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
Ma X; Yao J; Yue Y; Du S; Qin H; Hou J; Wu Z
Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):206-211. PubMed ID: 28475806
[TBL] [Abstract][Full Text] [Related]
33. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.
Zuckerbraun BS; McCloskey CA; Mahidhara RS; Kim PK; Taylor BS; Tzeng E
J Vasc Surg; 2003 Oct; 38(4):812-9. PubMed ID: 14560235
[TBL] [Abstract][Full Text] [Related]
35. The reversibility of canine vein-graft arterialization.
Fann JI; Sokoloff MH; Sarris GE; Yun KL; Kosek JC; Miller DC
Circulation; 1990 Nov; 82(5 Suppl):IV9-18. PubMed ID: 2225440
[TBL] [Abstract][Full Text] [Related]
36. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts.
Pintucci G; Saunders PC; Gulkarov I; Sharony R; Kadian-Dodov DL; Bohmann K; Baumann FG; Galloway AC; Mignatti P
FASEB J; 2006 Feb; 20(2):398-400. PubMed ID: 16303874
[TBL] [Abstract][Full Text] [Related]
37. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
38. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
[TBL] [Abstract][Full Text] [Related]
39. Differential response of arteries and vein grafts to blood flow reduction.
Galt SW; Zwolak RM; Wagner RJ; Gilbertson JJ
J Vasc Surg; 1993 Mar; 17(3):563-70. PubMed ID: 8445753
[TBL] [Abstract][Full Text] [Related]
40. Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure.
Wong CY; de Vries MR; Wang Y; van der Vorst JR; Vahrmeijer AL; van Zonneveld AJ; Roy-Chaudhury P; Rabelink TJ; Quax PH; Rotmans JI
J Vasc Surg; 2014 Jan; 59(1):192-201.e1. PubMed ID: 23684425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
